VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $210,336 | -7.7% | 7,339 | -22.5% | 0.05% | -16.4% |
Q3 2022 | $228,000 | -16.8% | 9,473 | -5.3% | 0.06% | -12.9% |
Q2 2022 | $274,000 | -29.9% | 10,004 | -1.8% | 0.07% | -19.5% |
Q1 2022 | $391,000 | +6.8% | 10,190 | -10.9% | 0.09% | +11.5% |
Q4 2021 | $366,000 | -76.3% | 11,440 | -78.2% | 0.08% | -78.0% |
Q3 2021 | $1,545,000 | -14.8% | 52,419 | -1.8% | 0.35% | -14.7% |
Q2 2021 | $1,814,000 | +4.7% | 53,372 | +0.2% | 0.42% | -3.0% |
Q1 2021 | $1,732,000 | -21.7% | 53,284 | -13.2% | 0.43% | -22.5% |
Q4 2020 | $2,212,000 | -62.7% | 61,406 | -59.4% | 0.55% | -56.9% |
Q3 2020 | $5,930,000 | -40.5% | 151,421 | -44.2% | 1.28% | -42.5% |
Q2 2020 | $9,961,000 | +88.4% | 271,565 | +18.4% | 2.23% | +48.1% |
Q1 2020 | $5,286,000 | +1069.5% | 229,406 | +1385.1% | 1.50% | +1360.2% |
Q4 2019 | $452,000 | +86.0% | 15,447 | +69.7% | 0.10% | +45.1% |
Q3 2019 | $243,000 | -2.4% | 9,100 | -6.7% | 0.07% | +1.4% |
Q2 2019 | $249,000 | – | 9,752 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $25,094,000 | 16.41% |
Windmill Hill Asset Management Ltd | 844,600 | $28,700,000 | 15.26% |
Hollow Brook Wealth Management LLC | 671,454 | $22,816,000 | 14.18% |
New Harbor Financial Group, LLC | 1,167,112 | $39,658,000 | 13.37% |
Grand Central Investment Group | 423,252 | $14,382,000 | 12.82% |
New Harbor Financial Group, LLC | 1,101,300 | $37,422,000 | 12.62% |
Cadence Wealth Management LLC | 432,124 | $14,684,000 | 12.40% |
Bienville Capital Management, LLC | 4,007,300 | $136,168,000 | 11.31% |
ONE PLUS ONE WEALTH MANAGEMENT, LLC | 460,504 | $15,648,000 | 10.79% |
Plaisance Capital LLC | 608,000 | $20,660,000 | 10.29% |